Specific Interaction between the Hepatitis Delta Virus RNA and Glyceraldehyde 3-Phosphate Dehydrogenase: An Enhancement on Ribozyme Catalysis  by Lin, Shyh-Shyan et al.
R
a
d
c
1
t
H
d
B
F
Virology 271, 46–57 (2000)
doi:10.1006/viro.2000.0302, available online at http://www.idealibrary.com onSpecific Interaction between the Hepatitis Delta Virus RNA and Glyceraldehyde
3-Phosphate Dehydrogenase: An Enhancement on Ribozyme Catalysis
Shyh-Shyan Lin,* Shin C. Chang,† Yun-Hsin Wang,* Chiao-Yin Sun,* and Ming-Fu Chang*,1
*Institute of Biochemistry and †Institute of Microbiology, College of Medicine, National Taiwan University, Taipei, Taiwan, Republic of China
Received October 11, 1999; returned to author for revision December 2, 1999; accepted March 8, 2000
Replication of hepatitis delta virus (HDV) RNA occurs in the nuclei of infected cells. The replication is mediated by cellular
factors containing an RNA polymerase II-like enzyme activity through a double rolling-circle mechanism and is regulated by
delta antigens. In this study, UV cross-linking experiments were carried out to examine interactions between HDV RNA and
proteins present in HeLa nuclear extract. Cellular proteins with molecular mass of 23 (p23), 36 (p36), 38 (p38), and 58 (p58)
kDa bound to full-length HDV RNA of both genomic and antigenomic strands. Deletion analysis on the antigenomic strand
mapped the interacting domain within a 79-nucleotide fragment but not at the ends of the rod-shaped viral RNA structure.
The specificity of the RNA-protein interactions was demonstrated by competition experiments and the specific HDV
RNA-binding proteins were purified through column chromatography. Electrophoresis mobility shift assay with the purified
fractions demonstrated that the interaction between p36 and HDV RNA was relatively stable even in the presence of 0.5 M
NaCl. Biochemical analysis including protein microsequencing identified the p36 as glyceraldehyde 3-phosphate dehydro-
genase (GAPDH). RNase footprinting indicated that the UC-rich domain between nucleotides 379 and 414 of the HDV
antigenomic RNA was involved in the GAPDH binding. Functional studies further demonstrated an enhancing effect of
GAPDH on the ribozyme activity of HDV antigenomic RNA. In addition, in the presence of HDV RNA cellular GAPDH
relocalized from the cytoplasm to the nucleus where HDV replication occurs. These results suggest that GAPDH is involved
in the replication of HDV. © 2000 Academic PressKey Words: hepatitis delta virus; HDV RNA-binding protein; glyceraldehyde 3-phosphate dehydrogenase (GAPDH); GAPDH-
binding site; HDV ribozyme; relocalization of GAPDH.
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Hepatitis delta virus (HDV) is the causative agent of
acute and chronic liver diseases including fulminant
hepatitis and accelerated liver cirrhosis (Hoofnagle,
1989). HDV particle contains a single-stranded circular
RNA genome of 1.7 kilobases with 60% of G1C content
and approximately 70% of intramolecular base pairing
that appears as a double-stranded, unbranched, rod-
shaped structure under nondenaturing conditions (Kos et
al., 1986; Makino et al., 1987a; Wang et al., 1986). HDV is
a satellite virus of hepatitis B virus (HBV) as it requires
HBV for virion production and transmission (Sureau et al.,
1993; Wang et al., 1991). However, replication of HDV
NA genome can occur in the absence of HBV (Kuo et
l., 1989). The HDV genomic RNA is associated with
elta antigen (HDAg) to form ribonucleoprotein (RNP)
omplex in virion and transfected cells (Chang et al.,
988, 1995; Lin et al., 1990; Ryu et al., 1993). There are
wo forms of delta antigen, small (HDAg-S) and large
DAg (HDAg-L). The HDAg-L is derived from the HDAg-S
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46s a result of RNA editing on the antigenomic strand
Casey and Gerin, 1995). A double-stranded RNA-aden-
sine deaminase, or a closely related host factor, was
uggested to be responsible for the editing event (Polson
t al., 1996).
HDV RNA replicates through a double rolling-circle
echanism with a host RNA polymerase II-like enzyme
ctivity to generate multimeric viral RNA precursors
Macnaughton et al., 1991; Fu and Taylor, 1993; Mac-
aughton et al., 1993b). The viral RNA precursors are
leaved into unit-length molecules by the intrinsic ri-
ozyme activity of HDV RNA (Kuo et al., 1988b; Sharmeen
t al., 1988; Wu et al., 1989). The ribozyme activity re-
uires a double pseudoknot structure and is important
or the viral replication (Ferre-D’Amare et al., 1998; Mac-
aughton et al., 1993b). Putative RNA promoters involved
n HDV replication and transcription have been charac-
erized (Beard et al., 1996; Macnaughton et al., 1993a; Tai
et al., 1993; Wang et al., 1997). But how a host DNA-
ependent RNA polymerase is capable of directing RNA
ynthesis with RNA templates remains unclear. Cellular
ouble-stranded RNA-dependent protein kinase (also
nown as DAI and p68 kinase) was found to be specifi-
ally associated with HDV RNA (Circle et al., 1997).
ucleolin and a cellular homolog of HDAg, delta-inter-
cting protein A (DIPA), were demonstrated to interact
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47GAPDH ENHANCES HDV RIBOZYME ACTIVITYwith HDAg and regulate HDV replication (Brazas and
Ganem, 1996; Lee et al., 1998). In addition, HDAg can
function as an RNA chaperone and modulate the ri-
bozyme activity of HDV RNA (Huang and Wu, 1998).
Previous studies also proposed the involvement of cel-
lular factors in the regulation of HDV ribozyme (Lazinski
and Taylor, 1995; Macnaughton et al., 1993b).
In this study, we demonstrated the specific binding of
ellular proteins p23, p36, p38, and p58 to both HDV
enomic and antigenomic RNAs. Amino-terminal se-
uencing identified the p36 as glyceraldehyde 3-phos-
hate dehydrogenase (GAPDH). GAPDH specifically
ound to the UC-rich domain of a 79-nucleotide (nt)
ragment, but not to the ends of the rod-shaped structure,
f the viral antigenomic RNA. In addition, cellular GAPDH
olocalized with HDV RNA in the nuclei of transfected
ells and was capable of enhancing the ribozyme activity
f an HDV antigenomic RNA. These results suggested
ossible roles of GAPDH involved in the multiplication of
DV.
RESULTS
nteractions between cellular proteins and HDV RNAs
For identification of putative cellular proteins that
nteract with HDV RNA and participate in the viral
ultiplication, UV cross-linking experiments were car-
ied out with a nuclear extract prepared from HeLa
ells. Two bands of approximately 23 and 58 kDa and
doublet of 36 and 38 kDa, designated p23, p58, p36,
nd p38, respectively, were detected with both full-
ength HDV genomic and antigenomic RNAs (Fig. 1).
he signals were not detected if the UV irradiation
tep was omitted or if the reaction mixtures were
reated with proteinase K prior to gel electrophoresis
data not shown), indicating that the signals were
FIG. 1. Detection of cellular proteins binding to HDV RNA by UV
ross-linking experiments. Full-length HDV genomic (lanes 1 and 2)
nd antigenomic (lanes 3 and 4) RNAs were subjected to UV cross-
inking in the absence (lanes 1 and 3) or presence (lanes 2 and 4) of
eLa nuclear extract. Arrows indicate proteins that cross-linked to the
DV RNAs. Numbers on the left indicate the sizes (in kilodaltons) of
tandard protein markers.erived from RNA-protein complexes formed via non-
ovalent linkage.
N
aDeletion mapping of the protein-binding domain on
HDV antigenomic RNA
To localize the interacting domain of HDV RNA with the
cellular proteins, RNA transcripts representing various
regions of the HDV antigenomic RNA were synthesized
in vitro in the presence of [a-32P]UTP and used as probes
in UV cross-linking experiments. Results indicated that
HDV antigenomic RNA spanning nt 966–225 (AG966/225)
contains protein binding sites, whereas nt 228–963
(AG228/963) failed to interact with the specific cellular
proteins (Fig. 2A, lanes 1 and 2). Further dissection of the
binding domain demonstrated that both HDV RNA frag-
ments nt 434–225 (AG434/225) and nt 434–356 (AG434/
356) were able to interact with the cellular proteins, but
the interaction was not detected with HDV AG966/431
RNA (Fig. 2A, lanes 3–5). Competition analysis was per-
formed using 32P-labeled AG434/225 RNA as a probe.
The UV cross-linked cellular proteins p58, p36/p38, and
p23 were significantly diminished in the presence of
increasing amounts of unlabeled AG434/225 RNA,
whereas nonhomologous TGEVE2 RNA competitor has
little effect (Fig. 2B). These results indicate that the cel-
lular proteins are capable of interacting specifically with
HDV RNA at a location outside the ends of the rod-
shaped RNA structure.
Purification of the HDV RNA-binding proteins and
characterization of the HDV RNA-p36 complexes
The HDV RNA-binding proteins present in the HeLa
nuclear extract were purified through column chromatog-
raphy and examined for their biochemical characteris-
tics. Following an initial step of DEAE-cellulose column
chromatography, RNA-binding activity of the HeLa nu-
clear extract was recovered from the flow-through frac-
tion as monitored by UV cross-linking experiment with
HDV AG434/225 RNA as a probe (Fig. 3B, lane INPUT).
The flow-through fraction was further passed onto a
heparin-Sepharose column and eluted with a discontin-
uous KCl gradient. Protein fractions were collected and
resolved by electrophoresis (Fig. 3A). UV cross-linking
experiments revealed that one of the HDV RNA-binding
proteins, p36, was present in the 0.2 M KCl fraction,
whereas p58, p38, and p23 were present in the 0.3 M KCl
fraction (Fig. 3B). Electrophoresis mobility shift assay
(EMSA) was further performed with the p36-containing
fraction using 32P-labeled HDV AG434/356 RNA as a
robe. As shown in Fig. 4A, two complexes were formed
lane C). The complexes were diminished with increas-
ng molar excesses of unlabeled AG434/356 RNA,
hereas a nonhomologous TGEVE2 RNA competitor had
o effect even at a 1000-fold molar excess (Fig. 4A). By
erforming binding reaction at various concentrations of
aCl, we found that the interaction between HDV RNA
nd p36 was relatively stable. A significant amount of the
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Standard protein markers and proteins that cross-linked to the viral
RNAs are indicated.
48 LIN ET AL.complexes was formed even at a salt concentration of
0.5 M (Fig. 4B).
Identification of the HDV RNA-binding protein p36 as
GAPDH
As demonstrated in Fig. 3A, the p36 HDV RNA-binding
protein appeared to be the major protein present in the
0.2 M KCl fraction following heparin-Sepharose column
chromatography. To learn the biochemical characteris-
tics of the p36, the 0.2 M KCl fraction was resolved by
electrophoresis on an SDS-15% polyacrylamide gel and
electrotransferred onto a polyvinylidene difluoride mem-
brane from which the p36 was excised for microse-
quence analysis. The amino acid sequence of p36 was
compared with known protein sequences in database.
As shown in Fig. 5, the NH2-terminal 21 amino acid
esidues of the p36 were identical to the human glycer-
ldehyde 3-phosphate dehydrogenase (GAPDH). Be-
ause no mixed protein sequences were detected, it is
ikely that the band of p36 represents GAPDH and no
ther proteins were comigrated with it on the polyacryl-
FIG. 3. Purification of cellular proteins that specifically bind to HDV
RNA. (A) Coomassie brilliant blue staining. Total HeLa nuclear extract
(NE) and protein fractions loaded onto (INPUT) and eluted from hepa-
rin-Sepharose column as indicated were resolved by electrophoresis
on an SDS-15% polyacrylamide gel followed by Coomassie brilliant
blue staining. Standard protein markers (M) are shown. (B) UV cross-
linking experiments. UV cross-linking experiments were performed
with AG434/225 RNA and protein fractions as indicated. Cross-linked
cellular proteins and standard protein markers are indicated. The
asterisk in (A) indicates the 36-kDa protein used to carry out microse-
quence analysis.FIG. 2. Deletion mapping of the HDV antigenomic RNA for the
binding of the specific cellular proteins. (A) Top: Schematic represen-
tation of the RNA fragments used in studying the interactions of HDV
antigenomic RNA with specific cellular proteins present in the HeLa
nuclear extract. The rod-shaped structure represented by a closed
heavy line indicates the antigenomic RNA of HDV. Open oval with
nucleotide numbers 0/1679 indicates the artificially designated end of
the viral genomic RNA. Nucleotides are numbered according to the
genomic orientation. Solid and dotted lines with arrowheads to indicate
the directions represent the viral antigenomic RNA fragments that
were, according to the present study, capable or unable, respectively, to
cross-link the specific HDV RNA-binding proteins. Restriction endo-
nucleases used to generate linear viral cDNA templates for the syn-
thesis of RNA transcripts are indicated along with the positions of their
recognition sequences. AG228/963 RNA on the right side of the rod-
shaped structure was derived from the BglII-SalI DNA fragment con-
taining nt 0/1679. AG966/225 RNA was derived from the SalI-BglII DNA
fragment containing nt 356. AG966/431 RNA was derived from the
SalI-NheI DNA fragment. Both AG966/225 and AG966/431 RNAs are
located on the left side of the rod-shaped structure. AG434/225 RNA
was derived from the NheI-BglII DNA fragment, and AG434/356 RNA
was derived from the HDV cDNA fragment from NheI site to nt 356 as
indicated. Bottom: UV cross-linking experiments. UV cross-linking ex-
periments were performed with 32P-labeled HDV antigenomic RNA
G228/963 (lane 1), AG966/225 (lane 2), AG966/431 (lane 3), AG434/225
lane 4), and AG434/356 (lane 5) in the presence of HeLa nuclear
xtract. (B) Competitive UV cross-linking experiments. Competition
nalysis was performed with HeLa nuclear extract and 32P-labeled
AG434/225 RNA in the presence of various amounts of unlabeled
homologous (AG434/225) or nonhomologous (TGEVE2) competitor RNA
as indicated. The amounts of competitors used were 50-, 200-, and
400-fold molar excess over the labeled AG434/225 RNA. Lane C rep-
resents a control experiment in which no competitor RNA was added.mide gel.
To confirm the identity of the p36 as human GAPDH,
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49GAPDH ENHANCES HDV RIBOZYME ACTIVITYfurther analyses were conducted in parallel with the
partially purified p36 and a commercial preparation of
GAPDH isolated from human erythrocytes. Results dem-
onstrated that the two proteins had similar electro-
phoretic migration patterns on SDS–polyacrylamide gel
(Fig. 6A) and were both recognized by a monoclonal
antibody specific for the rabbit muscle GAPDH in immu-
noblot analysis (Fig. 6B). In addition, the HDV RNA-
binding activity of p36 was also detected for the human
erythrocyte GAPDH by UV cross-linking analysis (Fig. 6C)
and EMSA (Fig. 6D). These data strongly support that the
HDV RNA-binding protein p36 is GAPDH.
FIG. 4. Specificity and stability of the complexes formed between the
36-containing fraction and HDV AG434/356 RNA. (A) Specificity of the
nteractions. Competitive EMSA was performed with 0.2 mg of the
p36-containing fraction, 32P-labeled HDV AG434/356 RNA, and 20 mg of
tRNA in the presence of increasing amount (40-, 200-, and 1000-fold
molar excesses) of unlabeled AG434/356 and TGEVE2 competitor
RNAs as indicated. Lane C represents a control experiment in which no
competitor RNA was added; P, probe only. RNA-protein complexes (CI
and CII) and free probe (F) are indicated. (B) Effect of ionic strength on
the complexes’ formation. Binding reactions were carried out with 0.2
mg of the p36-containing fraction, 32P-labeled HDV AG434/356 RNA,
and 3 mg of tRNA at increasing concentrations of NaCl (0.05, 0.1, 0.2,
0.5, and 1 M). The concentration of NaCl in standard binding reaction
was 50 mM. RNA-protein complexes (CI and CII) and free probe (F) are
indicated. P, probe only.
FIG. 5. Comparison of the NH2-terminal sequence of the p36 to
human GAPDH. The 36-kDa protein used to perform microsequence
analysis was purified from the 0.2 M KCl fraction as shown in Fig. 3A.G
a
The NH2-terminal sequences of the p36 and human GAPDH are shown.
he amino acid identity implies the p36 as human GAPDH.RNase footprinting analysis of the GAPDH binding
sites on HDV antigenomic RNA
To map the binding sites of GAPDH on HDV antigeno-
mic RNA, RNase footprinting analysis was conducted
with ribonucleoprotein complexes assembled from
GAPDH and d3 RNA that contains HDV antigenomic RNA
nt 434–356 flanking by extra sequences derived from the
cloning vector. The 79-nt RNA domain has been shown
to be responsible for the interaction between HDV anti-
genomic RNA and the p36 (Figs. 2 and 4). The reactions
were performed with RNase T1 followed by primer ex-
tension. Strand scission caused by RNase T1 treatment
resulted in an arrest of the primer-extended synthesis at
the nucleotide on the 39-side of the cleaved phosphodi-
ester bond. As shown in Fig. 7, in the presence of 1021
U/ml of RNase T1, cleavage occurred preferentially at
379, G396, G397, G402, and G414 in the absence of
FIG. 6. Similarity of the biochemical and immunogenic characteris-
tics of the HDV RNA-binding protein p36 and human GAPDH. The
partially purified p36 (lanes 1) and human erythrocyte GAPDH (lanes 2)
were characterized in parallel for their electrophoretic migration pat-
tern on an SDS-15% polyacrylamide gel as detected by silver staining
(A), the immunoreactive pattern as detected by monoclonal antibody to
rabbit muscle GAPDH (B), and the binding activity to HDV AG434/356
RNA as detected by UV cross-linking (C) and EMSA (D). The amounts
of the partially purified p36/human erythrocyte GAPDH used in these
studies were 0.1/0.2, 0.5/0.2, 0.2/0.5, and 0.2/0.2 (mg/mg) in (A), (B), (C),
and (D), respectively. Six and 3 mg of yeast tRNA were used in the
inding reaction of UV cross-linking and EMSA, respectively. The p36/
APDH (*), standard protein markers (M), RNA-protein complexes (CI
nd CII), and free probe (F) are indicated. P, probe only.APDH. GAPDH reduced significantly the RNase T1 re-
ctivity at all these positions, indicating an involvement
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50 LIN ET AL.of nt 379–414 of the HDV antigenomic RNA in the binding
of GAPDH. In addition, this defined GAPDH-binding do-
main is highly UC-rich. Many primer extension pause
sites detected in the absence of GAPDH disappeared at
a higher concentration of RNase T1 (1021 U/ml) and in the
resence of GAPDH, suggesting that the HDV RNA may
FIG. 7. Footprinting analysis of the HDV RNA bound by GAPDH. The
GAPDH binding sites on the HDV antigenomic RNA were determined
by RNase T1-primer extension analysis. The binding reaction was
performed with d3 RNA encompassing HDV antigenomic RNA nt 434–
356 in the absence (2) or presence (1) of GAPDH. RNase T1 digestion
was carried out at various concentrations as indicated. The primer-
extended products were analyzed on a 6% polyacrylamide gel contain-
ing 8 M urea. Sequencing ladders derived from cDNA of the d3 RNA
were run in parallel to serve as size markers. Autoradiography is
shown. Positions of the 39-terminal residue of the primer-extended
products and their neighboring guanosine residues protected by
GAPDH are indicated along with the sequence of the d3 RNA. Filled bar
(f) represents the primer and arrow points out the direction of primer
extension. Arrowheads () indicate potential RNase T1 cleavage sites,
but experimental results demonstrated that only some were completely
digested (F). Open circles (E) indicate those less sensitive or insen-
sitive to RNase T1. A doublet at G402 may be explained by the stutter-
ing effect of reverse transcriptase.orm a highly ordered structure that was modified upon
APDH binding and RNase T1 cleavage.APDH relocalized from cytoplasm to nucleus and
olocalized with HDV RNA in Huh 7 cells
GAPDH is a primarily cytoplasmic phosphoprotein
ith the ability to shuttle between the cytoplasm and
ucleus (Sirover, 1999). To examine possible functions of
he interaction between GAPDH and HDV RNA, Huh 7
ells were transfected with plasmid pSVD2 that repre-
ents the dimeric HDV cDNA (Chang et al., 1994), and
roceeded to fluorescence in situ hybridization/immuno-
luorescence staining. Interestingly, we found that
APDH relocalized from the cytoplasm to the nucleus
here the HDV RNA replicates (Fig. 8). These results
ndicate an association of GAPDH and viral RNA in vivo
nd strongly suggest that GAPDH plays an important role
n the replication of HDV by interacting with the viral
NA.
APDH enhanced the ribozyme activity of HDV RNA
GAPDH is a multifunctional protein (Sirover, 1997). It
as previously demonstrated to bind to ribozyme di-
ected against mRNA of tumor necrosis factor alpha
TNFa) and increase the in vitro cleavage rate of the
hammerhead-type ribozyme of TNFa mRNA (Sioud and
Jespersen, 1996). HDV ribozyme possesses a double
pseudoknot structure different from hammerhead (Ferre-
D’Amare et al., 1998). Although HDAg was recently dem-
onstrated to be capable of modulating the cis-cleavage
activity of HDV RNA (Huang and Wu, 1998), cellular fac-
tors that regulate HDV ribozyme activity have not been
clearly demonstrated. In this study, we made an attempt
to elucidate the biological significance of the interaction
between GAPDH and HDV RNA by examining the pos-
sible role of GAPDH on the catalysis of HDV ribozyme. As
shown in Fig. 9, the cis-cleavage activity of the HDV
antigenomic RNA AG966/225 increased from 34 to 62%
following a 40-min incubation with 50 ng/ml of GAPDH.
The enhancing effect of GAPDH on the catalysis of HDV
ribozyme was reproducible and was not observed with
bovine serum albumin (BSA). These results indicate the
specificity of the enhancing effect of GAPDH and a role
of GAPDH involved in HDV multiplication.
DISCUSSION
In this study, we have identified the HDV RNA-binding
protein p36 as GAPDH. GAPDH/p36 specifically inter-
acted with HDV RNA in vitro and relocalized from the
cytoplasm to the nucleus during HDV replication. In ad-
dition, GAPDH enhanced the ribozyme activity of the viral
antigenomic RNA. These results suggest a possible role
of GAPDH involved in HDV multiplication.
GAPDH was previously demonstrated to interact with
AU-rich mRNAs through the dinucleotide-binding Ross-
mann fold (Nagy and Rigby, 1995). In agreement with the
observation, we found that the formation of HDV RNA-
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51GAPDH ENHANCES HDV RIBOZYME ACTIVITYp36/GAPDH complexes was diminished in the presence
of poly(U) and poly(A), with the former demonstrating a
stronger effect (data not shown); however, comparison
among GAPDH-associated RNA fragments (De et al.,
1996; Nagy and Rigby, 1995; Singh and Green, 1993;
Sioud and Jespersen, 1996) did not reveal any apparent
sequence similarity. Similar to the GAPDH-interacting
RNAs, sequence diversity was also observed for RNAs
that interact with polypyrimidine tract-binding protein
(PTB) (Garcia-Blanco et al., 1989; Hellen et al., 1994; Jang
and Wimmer, 1990; Mulligan et al., 1992). Higher-ordered
structures with U-rich motifs in the RNAs may be impor-
tant for the initial recognition of the RNA-binding pro-
teins. GAPDH was demonstrated to form complexes with
RNAs of hepatitis A virus (HAV) and human parainfluenza
virus type 3 (HPIV3) (De et al., 1996; Schultz et al., 1996).
However, HDV RNA has a unique characteristic to form
two complexes with GAPDH rather than one (Fig. 6).
Since GAPDH can exist as tetramer, monomer, and pos-
sibly dimer in an equilibrium (Constantinides and Deal,
1969), it is likely that HDV RNA interacted with GAPDH of
different forms.
Previous studies have identified a number of cellular
FIG. 8. Fluorescence in situ hybridization/immunofluorescence stainin
cells. Huh 7 cells were seeded onto coverslips and allowed to adher
DV cDNA. Untreated Huh 7 cells (a, b, and c) and the pSVD2-transfe
luorescence in situ hybridization/immunofluorescence staining using m
f) as the primary antibodies. The cellular GAPDH and the HDV RNA th
Red-conjugated horse anti-mouse antibodies and FITC-conjugated ra
contrast micrographs (a) and (d) represent cells of the same fields asproteins that associated with both HDAg and HDV RNA
and participated in the viral replication (Brazas and Ga-
w
enem, 1996; Lee et al., 1998; Polson et al., 1996). In this
study, p23, p36/GAPDH, p38, and p58, present in the
HeLa nuclear extract were identified to interact with both
HDV genomic and antigenomic RNAs (Fig. 1). These
proteins are also present in the nuclear extracts of Huh
7 and HepG2 cells (data not shown) and are likely to be
common cellular factors. Although functional roles of
p36/GAPDH in the nuclei are not fully understood, at
least four glycolytic enzymes, including GAPDH, were
detected in cell nuclei and found to interact with DNA in
vitro (Ronai, 1993). GAPDH was also demonstrated to
interact with tRNA (Singh and Green, 1993), mRNA (Nagy
and Rigby, 1995), microtubules (Kumagi and Sakai, 1983),
red cell membrane (Kant and Steck, 1973), and several
proteins involved in neurodegenerative disorders (Burke
et al., 1996; Koshy et al., 1996; Schulze et al., 1993).
Multiple functions have been attributed to GAPDH in
addition to glycolysis. These include DNA replication
(Baxi et al., 1995), DNA repair (Meyer-Siegler et al., 1991),
rotein phosphorylation (Kawamoto and Caswell, 1986),
nd neuronal apoptosis (Ishitani et al., 1996; Sunaga et
l., 1995). GAPDH from rabbit muscle was demonstrated
o greatly stimulate RNA polymerase II transcription
cted nuclear colocalization of GAPDH and HDV RNA in transfected Huh
ight before transfection of plasmid pSVD2 that represents the dimeric
ells (d, e, and f) were fixed 2 days posttransfection and proceeded to
Ab against GAPDH (b and e) and goat antiserum against biotin (c and
dized to the biotin-labeled probe were then visualized by using Texas
ti-goat antibodies, respectively, as the secondary antibodies. Phase-
(c), and (e) and (f), respectively.g dete
e overn
cted c
ouse m
at hybri
bbit anhen injected into Xenopus laevis oocytes (Morgenegg
t al., 1986). GAPDH was also demonstrated to destabi-
A
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52 LIN ET AL.lize helix and folded structures (Karpel and Burchard,
1981; Schultz et al., 1996) and to enhance the ribozyme
activity of hammerhead RNA (Sioud and Jespersen,
1996).
Given that HDV RNA appeared as a double-stranded,
rod-shaped structure under nondenaturing conditions, it
FIG. 9. Enhancing effect of GAPDH on the cis-cleavage activity of H
AG966/225. HDV antigenomic RNA AG966/225 was in vitro transcribed
resolving the transcription products on a 4% polyacrylamide gel con
AG966/225 RNA substrate, the 39 and 59 cleavage products, respectively
RNA marker (lane M) was synthesized with T7 RNA polymerase in the p
with EcoRI restriction endonuclease. Sequencing ladders derived from
cis-cleavage products of the HDV AG966/225 RNA in the presence of G
were cosynthesized in vitro and incubated with various amounts of GAP
were analyzed on a 6% polyacrylamide gel containing 7 M urea. Aut
resulted from the multiple sites of initiation and runoff of T7 RNA pol
G966/225 RNA in the presence of GAPDH. Radioactivities of the cleav
Molecular Dynamics) and normalized against the uncleavable interna
ividing the molar ratio of the sum of the cleavage products and uncl
ncubation time. The fraction of uncleaved substrate at 0 min of incubis reasonable to expect that during HDV multiplication,
cellular helicases are involved in unwinding the double-stranded RNA template and facilitating the release of
progeny RNA from template following replication. Previ-
ous studies also suggested that cellular factors are in-
volved in regulating the ribozyme activity of the HDV
genomic strand, possibly by preventing its association
with the ribozyme attenuator (Lazinski and Taylor, 1995).
igenomic RNA. (A) Cis-cleavage activity of the HDV antigenomic RNA
presence of [a-32P]UTP and its cis-cleavage activity was examined by
7 M urea. Autoradiography is shown. S, 39P, and 59P represent the
39P9 are possibly the conformers of S and 39P, respectively. The 838-nt
e of [a-32P]UTP from plasmid pGEM4Z-C191 (Yen et al., 1995) linearized
mp18 DNA were run in parallel to serve as size markers. (B) The 59
HDV antigenomic RNA AG966/225 and the internal control RNA (IC63)
d BSA for various time periods as indicated. The cis-cleavage products
raphy is shown. The multiple bands of cleavage products and IC63
e (Milligan et al., 1987). (C) The relative ribozyme activity of the HDV
ducts and uncleaved substrates were quantitated by PhosphorImager
ol IC63 RNA. The fraction of uncleaved substrate was calculated by
ubstrates into the uncleaved substrates and was plotted against the
as 66%.DV ant
in the
taining
. S9 and
resenc
M13
APDH.
DH an
oradiog
ymeras
age pro
l contrAlthough HDV ribozyme is different from hammerhead or
hairpin ribozyme, it is worth noting that GAPDH in-
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53GAPDH ENHANCES HDV RIBOZYME ACTIVITYcreased the in vitro cleavage rate of the hammerhead
ribozyme of TNFa mRNA, presumably via the RNA un-
olding activity of GAPDH (Sioud and Jespersen, 1996).
In this study, we consistently detected a twofold en-
ancing effect of GAPDH on the cis-cleavage activity of
he HDV antigenomic RNA. This result is significant as in
he in vitro transcription system, we consistently ob-
erved a basal cis-cleavage activity at 30–35% (Fig. 9). In
ddition, a complete cleavage is unlikely to happen, as
ncleaved products are always found in the replication
ycle of HDV RNA (Makino et al., 1987b). Furthermore,
the effect of GAPDH on the catalysis of HDV ribozyme
was not observed with BSA (Fig. 9), indicating that the
enhancing effect of GAPDH is specific. Athough the
underlying mechanism of the enhancing effect remains
to be elucidated, it is likely that GAPDH acts as a mo-
lecular chaperone to unwind the double-stranded rod-
shaped RNA structure and render the nascent viral RNA
in a conformation with double pseudoknot structure suit-
able for the cleavage. In agreement with the role of the
glycolytic enzyme GAPDH in regulating HDV ribozyme
activity important for the viral multiplication, an earlier
study with transgenic mice system has demonstrated
that the replication of HDV RNA occurred in most tissues
but exhibited at a higher level in the skeletal muscle
(Polo et al., 1995), a tissue that undergoes extensive
glycolytic process. Further studies are required to eluci-
date possible roles of the other three HDV RNA-binding
proteins identified in this study on the multiplication of
HDV.
MATERIALS AND METHODS
Cell line and culture condition
HeLa cells (a human cervical carcinoma cell line)
adapted to suspension culture were grown at 37°C in
RPMI medium supplemented with 5% fetal calf serum
plus 100 units of penicillin and 100 mg of streptomycin/
ml.
Preparation of HeLa nuclear extract
Nuclear extract was prepared from HeLa cells grown
to mid-log phase, followed the procedures as described
previously (Dignam et al., 1983). In brief, cells were har-
vested by centrifugation for 10 min at 1000 g and washed
twice with cold phosphate-buffered saline (PBS). The cell
pellet was resuspended in five packed cell volumes of
buffer A containing 10 mM N-2-hydroxyethylpiperazine-
N9-2-ethanesulfonic acid (HEPES), pH 7.9, 1.5 mM MgCl2,
0 mM KCl, and 0.5 mM dithiothreitol (DTT), and allowed
o stand for 10 min at 4°C. The cells were then collected
nd disrupted using a Dounce homogenizer in two
acked cell volumes of the buffer A. Nuclei were pelletedrom the homogenate by centrifugation at 1000 g for 10
in then 25,000 g for 20 min. The nuclei were resus-
R
Hended in buffer C containing 20 mM HEPES, pH 7.9, 25%
lycerol, 0.42 M NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5
mM phenylmethylsulfonyl fluoride (PMSF), and 0.5 mM
DTT, stirred for 30 min and subjected to centrifugation for
30 min at 25,000 g. The supernatant was collected and
dialyzed against buffer D containing 20 mM HEPES, pH
7.9, 20% glycerol, 0.2 mM EDTA, 0.5 mM PMSF, and 0.5
mM DTT supplemented with 0.1 M KCl for 5 h. The
dialysate was further clarified by centrifugation for 20
min at 25,000 g and the resulting nuclear extract was
rozen as aliquots to store at 280°C.
lasmid construction
Plasmid p4B. Plasmid p4B contains a single copy of
he full-length HDV cDNA and was used to generate HDV
G228/963 RNA transcript. For construction of plasmid
4B, a 1679-bp BglII DNA fragment was isolated from
D2 (Chang et al., 1993), treated with the Klenow frag-
ent of DNA polymerase I, and subcloned into the
nique XbaI site, which had been blunted with the Kle-
ow fragment of DNA polymerase I, of pGEM4Z vector
Promega).
Plasmids pBN and pBNd3. Plasmid pBN contains
DNA representing HDV RNA sequence nt 225–434 (nu-
leotides are numbered as described previously [Kuo et
l., 1988a]) and was used to generate HDV AG434/225
NA. For construction of plasmid pBN, a 210-bp BglII-
heI DNA fragment was isolated from pD1 (Chang et al.,
993), treated with the Klenow fragment of DNA polymer-
se I, and subcloned into modified pGEM4Z from which
he polylinker sequence from EcoRI to XbaI site had been
eleted and the remaining DNA blunted with the Klenow
ragment of DNA polymerase I. Plasmid pBNd3 contains
DNA representing HDV RNA nt 356–434 and was used
o generate HDV AG434/356 and d3 RNA. For construc-
ion of plasmid pBNd3, plasmid pBN was digested with
alI plus PstI, treated with exonuclease III and mung
ean exonuclease, and self-ligated after a treatment of
4 DNA polymerase.
reparation of RNA transcripts
RNA transcripts were synthesized in vitro from linear-
zed DNA templates containing the promoter sequences
or SP6 or T7 RNA polymerase. In vitro transcription was
erformed as described previously (Chang et al., 1993).
o generate 32P-labeled RNA probes, in vitro transcrip-
tion was performed in the presence of [a-32P]UTP (3000
i/mmol).
HDV G-RNA and AG-RNA. HDV G-RNA and AG-RNA
epresent the full-length HDV genomic and antigenomic
NA, respectively. The G-RNA was synthesized with SP6
NA polymerase from plasmid pD1 linearized with
amHI, whereas the AG-RNA was synthesized with T7
NA polymerase from plasmid pD1 linearized with
indIII.
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54 LIN ET AL.AG966/431 and AG966/225. AG966/431 and AG966/
225, representing HDV antigenomic RNA nt 966–431 and
966–225 (nucleotides are numbered according to the
genomic orientation), were synthesized with T7 RNA
polymerase from plasmid pD1 linearized with NheI and
BglII, respectively.
AG228/963, AG434/225, and AG434/356. AG228/963
represents HDV antigenomic RNA nt 228–1 plus nt
0/1679–963, and AG434/225 represents HDV antigeno-
mic RNA nt 434–225. These two RNA transcripts were
synthesized with SP6 RNA polymerase from SalI-linear-
ized plasmid p4B and pBN, respectively. AG434/356 rep-
resenting HDV antigenomic RNA nt 434–356 was synthe-
sized with SP6 RNA polymerase from plasmid pBNd3
linearized with HindIII.
d3 RNA. For synthesis of d3 RNA transcript, a 144-bp
NA fragment was first generated by polymerase chain
eaction using pBNd3 as the template and SP6 and T7
romoter sequences as the primers. In vitro transcription
as performed with SP6 RNA polymerase. The d3 RNA
ncompasses HDV antigenomic RNA nt 434–356 flank-
ng by an extra 11 nt at the 59-end and 37 nt at the 39-end
hat were derived from the vector sequence of plasmid
BNd3.
TGEVE2 RNA. The 159-nt TGEVE2 RNA was prepared
s previously described (Yen et al., 1995) and was used
s a nonhomologous competitor to study the specific
nteractions between HDV RNA and cellular proteins.
IC63 RNA. The 63-nt IC63 RNA was synthesized with
7 RNA polymerase from EcoRI-linearized pGEM4Z and
as used as an internal control in the cis-cleavage
eaction of HDV ribozyme.
V cross-linking experiment
UV cross-linking experiments were performed with
a-32P]UTP-labeled RNA (1 3 106 cpm) and 20 mg of HeLa
uclear extract, or indicated amounts of human erythro-
yte GAPDH (Sigma) and protein fractions of HeLa nu-
lear extract purified through column chromatography.
he binding reactions were carried out at 30°C for 30
in in a buffer containing 10 mM Tris–HCl, pH 8.0, 1 mM
DTA, 50 mM NaCl, 0.02% Ficoll, 0.02% polyvinylpyrroli-
one, 0.02% BSA, and 20 mg or otherwise indicated
amounts of yeast tRNA. The reaction mixtures were
transferred into wells of a microtiter plate seated on ice,
UV-irradiated (254 nm, Model UVGL-58, Ultra-Violet Prod-
ucts, Inc.) for 30 min at a distance of 4 cm, followed by a
digestion at 37°C for 30 min with 30 mg RNase A (Sigma)
and 30 units RNase T1 (Roche Molecular Biochemicals).
The UV cross-linked products were separated on an
SDS-15% polyacrylamide gel. The gel was fixed, dried,
and exposed to X-ray film. In competition experiments,
various amounts of unlabeled competitor RNA were
added into the reaction mixtures 10 min prior to the
addition of 32P-labeled RNA probe.
c
IElectrophoresis mobility shift assay (EMSA)
To perform electrophoresis mobility shift assay, pro-
tein-RNA binding reactions were carried out as de-
scribed in the UV cross-linking experiments, except that
[a-32P]UTP-labeled RNA probe at 2 3 104 cpm with com-
parable specific activity was used. The reaction mixtures
were subjected to electrophoresis on a 5% nondenatur-
ing polyacrylamide gel [acrylamide:bisacrylamide weight
ratio of 79:1 in 0.53 TBE (13 TBE: 90 mM Tris–borate, 2
M EDTA, pH 8.0) and 5% glycerol] and the RNA-protein
omplexes were visualized by autoradiography. Compe-
ition study was performed with unlabeled RNA as de-
cribed for the UV cross-linking competition experi-
ents.
urification of HDV RNA-binding proteins
For purification of cellular proteins that interact with
DV RNA, HeLa nuclear extract that was prepared and
ialyzed against buffer D supplemented with 0.1 M KCl
s described earlier was loaded onto a DEAE-cellulose
Whatmann) column preequilibrated with the same
uffer. Because the flow-through fraction was found to
ontain HDV RNA-binding activity, it was loaded further
nto a heparin-Sepharose (Amershan Pharmacia Bio-
ech) column preequilibrated with the 0.1 M KCl-supple-
ented buffer D. The column matrix was washed with 20
olumn volumes of the same buffer and cellular proteins
ere eluted with 4 column volumes of each of buffer D
ontaining 0.2, 0.3, and 0.4 M KCl. Fractions were col-
ected and examined for their binding activities to HDV
NA.
rotein sequence analysis
Cellular proteins partially purified through heparin-
epharose column were precipitated by trichloroacetic
cid, resolved by electrophoresis on an SDS-15% poly-
crylamide gel, and electrotransferred onto a polyvinyli-
ene difluoride membrane (Millipore). The membrane
as stained with Coomassie brilliant blue, and the major
and corresponding to a 36-kDa protein was excised.
he protein was sequenced by using a model 477A
equenator (Applied Biosystems) equipped with an on-
ine 120A phenylthiohydantoin amino acid derivative an-
lyzer.
mmunoblot analysis
Immunoblot analysis was performed as described pre-
iously (Chang et al., 1993). Briefly, proteins were elec-
rophoresed on an SDS-15% polyacrylamide gel and
lectrotransferred onto a polyvinylidene difluoride mem-
rane. Immunoreactive bands were visualized by suc-
essive incubations of the membrane with mouse mono-
lonal antibody to GAPDH of rabbit muscle (Biodesign
nternational) and horseradish peroxidase-conjugated
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55GAPDH ENHANCES HDV RIBOZYME ACTIVITYgoat anti-mouse IgG antibody. Color development was
performed using 3,39-diaminobenzidine tetrahydrochlo-
ride as a substrate.
RNase footprinting analysis
RNase footprinting-primer extension analysis was car-
ried out as described previously (Ito and Lai, 1997; Ko-
lupaeva et al., 1996) with modifications. In brief, the
inding reactions were performed with HDV d3 RNA and
he human erythrocyte GAPDH at 30°C for 30 min as
escribed in the UV cross-linking experiments, except
hat 3 mg of yeast tRNA was added. A 10-min incubation
was followed after an addition of various amounts of
RNase T1 (Roche Molecular Biochemicals) and the re-
sulting RNA mixtures served as templates to perform
primer extension in analyzing the sizes of the RNA prod-
ucts. Annealing reactions of the primer extension were
performed at 85°C for 3 min with a [g-32P]ATP-labeled
rimer containing sequences of T7 RNA polymerase
romoter, in an annealing buffer containing 40 mM Tris–
Cl, pH 7.5, 25 mM MgCl2, and 50 mM NaCl. The an-
nealing reaction mixtures were incubated at 37°C in a
period of 20–30 min, then kept on ice for 5 min prior to
the extension reaction with avian myeloblastosis virus
reverse transcriptase (Life Technologies, Inc.) at 37°C for
30 min in a buffer containing 50 mM Tris–HCl, pH 7.5, 75
mM KCl, 10 mM DTT, 100 mg of BSA/ml, and 1 mM dNTP.
The reaction was terminated by adding a stop solution
containing 95% formamide, 20 mM EDTA, 0.05% brom-
phenol blue, and 0.05% xylene cyanol. Aliquots of 5 ml
were boiled for 3 min, and subjected to electrophoresis
on a 6% polyacrylamide gel containing 8 M urea.
Fluorescence in situ
hybridization/immunofluorescence staining
Fixation/permeabilization of cultured cells was per-
formed as previously described (Carmo-Fonseca et al.,
1991). Briefly, cells on coverslips were washed twice in
PBS, pH 7.4, permeabilized by covering with a CKS buffer
(100 mM NaCl, 300 mM sucrose, 10 mM 1,4-piperazinedi-
ethanesulfonic acid, pH 6.8, 3 mM MgCl2) containing
.5% Triton X-100 and 1 mM PMSF for 3 min on ice and
ixed in the CKS buffer containing 3.7% paraformalde-
yde for 10 min at room temperature. To detect HDV
NA, the fixed cells were washed in PBS and incubated
ith HDV AG434/225 RNA prelabeled with biotin-14-CTP
Life Technologies, Inc.). The final concentration of the
iotinylated RNA probe was 30 nM, and the in situ
ybridization was carried out in a reaction buffer con-
aining 40% formamide, 43 SSC (0.3 M NaCl, 0.03 M
odium citrate, pH 7.0), 0.1 M potassium phosphate
uffer, pH 7.0, 300 mg/ml sonicated salmon sperm DNA,
nd 300 mg/ml yeast tRNA at 42°C overnight in a humid-ified chamber. The cells were then rinsed with 23 SSC,
followed by extensive washing three times with 50%formamide/23 SSC at 45°C for 3 min each, and once
with PN buffer (1 M NaH2PO4, 1 M Na2HPO4, 1% NP-40,
H 8.0) for 5 min at room temperature prior to double
mmunofluorescence staining. Hybridization of the biotin-
abeled probe to the HDV RNA was detected by goat
ntiserum against biotin (Vector) and fluorescence iso-
hiocyanate (FITC)-labeled rabbit anti-goat antibodies
Jackson ImmunoResearch Laboratories, Inc.). Cellular
APDH was detected by mouse mAb to GAPDH (Biode-
ign) and Texas Red-labeled horse anti-mouse antibod-
es (Vector). Photographs were taken using a Zeiss Ax-
ophot microscope equipped with epifluorescence.
is-cleavage reaction of HDV ribozyme
Cis-cleavage reaction was carried out as previously
escribed (Huang and Wu, 1998) with modifications.
riefly, HDV antigenomic RNA AG966/225 and an internal
ontrol RNA IC63 were cosynthesized in vitro with T7
NA polymerase and incubated with various amounts of
APDH or BSA in a total volume of 20 ml containing 40
M Tris–HCl, pH 7.5, 100 mM NaCl, 0.02 mM EDTA, 2%
lycerol, and 12 mM MgCl2. At 20-min intervals, 4-ml
aliquots were removed from the reaction mixtures and 5
ml of a stop solution containing 50 mM EDTA, 7 M urea,
0.005% bromphenol blue, and 0.005% xylene cyanol were
added. The reaction products were resolved on poly-
acrylamide gels containing 7 M urea. Radioactivities of
the cleavage products and uncleaved substrates were
quantitated by PhosphorImager (Molecular Dynamics)
and normalized against the uncleavable internal control
IC63 RNA.
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